Comparison of two free light chain assays: performance of the involved free light chain ratio and implications for diagnosis of multiple myeloma

被引：2
|
作者：
Willrich, Maria Alice V. [1 ]
Murray, David L. [1 ]
Rajkumar, S. Vincent [2 ]
Bryant, Sandra C. [3 ]
Larson, Dirk [3 ]
Pazdernik, Vanessa [3 ]
Snyder, Melissa R. [1 ]
Kyle, Robert A. [2 ]
Dispenzieri, Angela [1 ,2 ]
机构：
[1] Mayo Clin, Dept Lab Med & Pathol, Rochester, MN 55905 USA
[2] Mayo Clin, Div Hematol, Rochester, MN 55905 USA
[3] Mayo Clin, Div Clin Trials & Biostat, Dept Quantitat Hlth Sci, Rochester, MN USA
来源：
BLOOD CANCER JOURNAL | 2022年 / 12卷 / 09期
关键词：
MONOCLONAL GAMMOPATHIES; PROGRESSION; CRITERIA; RISK;
D O I：
10.1038/s41408-022-00722-5
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：4
相关论文
共 50 条
  • [1] Evaluating serum free light chain ratio as a biomarker in multiple myeloma
    Akhlaghi, Theresia
    Maclachlan, Kylee
    Korde, Neha
    Mailankody, Sham
    Lesokhin, Alexander M.
    Hassoun, Hani
    Lu, Sydney X.
    Patel, Dhwani
    Shah, Urvi A.
    Tan, Carlyn R.
    Derkach, Andriy
    Lahoud, Oscar B.
    Landau, Heather J.
    Shah, Gunjan L.
    Scordo, Michael
    Chung, David J.
    Giralt, Sergio A.
    Usmani, Saad Z.
    Landgren, Ola
    Hultcrantz, Malin
    HAEMATOLOGICA, 2025, 110 (02) : 493 - 497
  • [2] Analysis of patients with γ-heavy chain disease by the heavy/light chain and free light chain assays
    Kaleta, Erin
    Kyle, Robert
    Clark, Raynell
    Katzmann, Jerry
    CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2014, 52 (05) : 665 - 669
  • [3] Involved free light chain: an early independent predictor of response and progression in multiple myeloma
    Gran, Charlotte
    Afram, Gabriel
    Liwing, Johan
    Verhoek, Andre
    Nahi, Hareth
    LEUKEMIA & LYMPHOMA, 2021, 62 (09) : 2227 - 2234
  • [4] Comparison of serum free light chain and urine electrophoresis for the detection of the light chain component of monoclonal immunoglobulins in light chain and intact immunoglobulin multiple myeloma
    Dejoie, Thomas
    Attal, Michel
    Moreau, Philippe
    Harousseau, Jean-Luc
    Avet-Loiseau, Herve
    HAEMATOLOGICA, 2016, 101 (03) : 356 - 362
  • [5] Comparison of three different serum-free light-chain assays-implications on diagnostic and therapeutic monitoring of multiple myeloma
    Schieferdecker, Aneta
    Hoerber, Sebastian
    Ums, Monika
    Besemer, Britta
    Bokemeyer, Carsten
    Peter, Andreas
    Weisel, Katja
    BLOOD CANCER JOURNAL, 2020, 10 (01)
  • [6] Limitations of Free Light Chain Assays caused by the Matrix Effect
    Farnsworth, Christopher W.
    Logsdon, Nicole M.
    Hayes, Jennifer E.
    Rais, Rehan
    Willrich, Maria A.
    Gronowski, Ann M.
    JOURNAL OF APPLIED LABORATORY MEDICINE, 2020, 5 (02) : 311 - 319
  • [7] Serum free light chain analysis in the diagnosis and management of multiple myeloma and related conditions
    Graziani, Maria Stella
    Merlini, Giampaolo
    EXPERT REVIEW OF MOLECULAR DIAGNOSTICS, 2014, 14 (01) : 55 - 66
  • [8] Serum free light chain ratio as a biomarker for high-risk smoldering multiple myeloma
    Larsen, J. T.
    Kumar, S. K.
    Dispenzieri, A.
    Kyle, R. A.
    Katzmann, J. A.
    Rajkumar, S. V.
    LEUKEMIA, 2013, 27 (04) : 941 - 946
  • [9] Normalization of free light chain kappa/lambda ratio is a robust prognostic indicator of favorable outcome in patients with multiple myeloma
    Iwama, Kan-ichi
    Chihara, Dai
    Tsuda, Kenji
    Ugai, Tomotaka
    Sugihara, Hiroyuki
    Nishida, Yuhki
    Yamakura, Masayuki
    Takeuchi, Masami
    Matsue, Kosei
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2013, 90 (02) : 134 - 141
  • [10] Serum-free light-chain analysis in diagnosis and management of multiple myeloma and related conditions
    Milani, Paolo
    Palladini, Giovanni
    Merlini, Giampaolo
    SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION, 2016, 76 : S113 - S118
12345